Indications |
Oral Susceptible infections Adult: 150 mg bid or 300 mg once daily for 5-10 days in susceptible infections. Child: 6-40 kg: 5-8 mg/kg daily. Renal impairment: Dosage adjustment may be required. Hepatic impairment: Usual daily doses should be halved in hepatic impairment. Special Populations: Cirrhosis: 150 mg once daily. |
Contraindications |
Hypersensitivity. Porphyria. |
Warnings / Precautions |
Hepatic impairment. Monitor liver function. Prolonged treatment increases risk of hepatotoxicity. History of arrhythmias. |
Adverse Reactions |
Nausea, vomiting, abdominal pain, diarrhoea, weakness, malaise, anorexia, constipation, dyspepsia, flatulence; hepatitis; rashes, headache, dizziness, weakness, changes in blood counts; increased liver enzyme values; eosinophilia; rarely, acute pancreatitis. |
Drug Interactions |
May raise serum levels of ciclosporin and digoxin. Increased risk of rhabdomyolysis when used with simvastatin. See Below for More roxithromycin Drug Interactions |
Mechanism of Actions |
Roxithromycin inhibits protein synthesis by irreversibly binding to the 50s ribosomal subunits thus blocking the transpeptidation or translocation reactions of susceptible organisms resulting in stunted cell growth. Absorption: Plasma concentrations peak after 2 hr (oral); reduced if taken after food. Bioavailability: about 50%. Distribution: Widely distributed into body tissues and fluids. Protein-binding: 96% at trough concentrations. Metabolism: Small amounts are metabolised in the liver. Excretion: Mainly via the faeces as unchanged drug and metabolites, via the urine (7-12%) and the lungs (15%). Elimination half-life: 8-13 hr. May be prolonged in renal and hepatic impairment, children. |
Administration |
Should be taken on an empty stomach. (Take before meals.) |
ATC Classification |
J01FA06 - roxithromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections. |
Available As |
|
Roxithromycin
Post Review about Roxithromycin Click here to cancel reply.
Roxithromycin Containing Brands
Roxithromycin is used in following diseases
Drug - Drug Interactions of Roxithromycin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.